查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576505

生物反應器市場規模,佔有率,預測,趨勢分析：按類型、生物製程、效用、規模、細胞類型、應用、使用者 - 到 2031 年的全球預測

Bioreactors Market Size, Share, Forecast, & Trends Analysis by Type, Bioprocess, Usability, Scale, Cell Type, Application, User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 260 Pages | 商品交期: 5-7個工作天內

價格

預計到2031年，全球生物反應器市場將達到399.6億美元，2024年至2031年複合年增長率為10.1%。

該報告基於全面的一手和二手研究以及對市場情景的深入分析，深入瞭解了生物反應器市場的關鍵推動因素、市場限制、機會和課題。市場成長的推動因素包括生物製藥工廠的擴張、製藥業的成長、藥品研發支出的增加、生物相似藥的採用增加以及製藥和生物技術領域一次性技術的採用增加。然而，生物製藥開發和製造過程的複雜性以及生物製藥製造所需的高資本需求限制了市場成長。

此外，生物反應器技術的進步以及個人化藥物以及細胞和基因療法的更多採用預計將創造市場成長機會。然而，使用一次性生物反應器的生物製造過程中與可提取物和可浸出物(E&L) 相關的風險、擴大生物製藥過程的限制、標準化一次性生物反應器設計的需要、與廢棄生物反應器相關的環境問題是其中一些因素。

從產品來看，預計到 2024 年，連續攪拌釜生物反應器領域將佔據生物反應器市場的最大佔有率，達到 31%。該領域的巨大市場佔有率歸因於連續攪拌罐生物反應器的技術進步以及由於其與其他生物反應器相比具有優越的傳熱性能而能夠處理高濃度反應物。此外，市場參與者正在增強生物反應器設計，以便與現有流動系統無縫整合。例如，2024年10月，Vapourtec Ltd.（英國）推出了專為連續製程合成而設計的連續攪拌槽生物反應器。

基於生物工藝，預計到 2024 年，分批/補料分批細分市場將佔據生物反應器市場的最大佔有率。此細分市場的龐大市場佔有率歸因於分批/補料分批生物製程的優勢，例如高生產率、簡化的生物製程管理和降低的污染風險。批次持續時間非常適合快速實驗、加速上游流程和提高整體生產力。

按細胞類型劃分，預計到 2024 年，哺乳動物細胞將在生物反應器市場中佔據最大佔有率。該細分市場的巨大市場佔有率歸因於對單株抗體和治療性蛋白質等複雜生物分子的商業和研究生物生產的日益關注。此外，涉及哺乳動物細胞的臨床研究的增長促使一次性生物反應器的廣泛採用。

基於易用性，預計到 2024 年，可重複使用的生物反應器領域將在生物反應器市場中佔據更大的佔有率。該領域的巨大市場佔有率歸因於大規模製造的增加，而可重複使用的生物反應器由於其成本效益和適合大批量生產而得到越來越多的採用。此外，與廢物處理相關的高成本和監管限制正在推動可重複使用生物反應器的廣泛採用。

以規模計算，中試規模生物反應器（10L-200L）領域預計將創下市場最高複合年增長率。中試規模生物反應器是容量從 10L 到 200L 不等的系統，可提供多種變化和客製化。中試生物反應器在食品、製藥和化妝品行業中有著廣泛的應用，主要用於在大規模生產之前測試和完善生物製程。對商業生物生產的需求不斷增長將推動中試規模生物加工的採用。這是因為這些生物反應器對於評估其在接近工業環境的條件下的效率、可擴展性和性能至關重要。

基於自動化，自動化生物反應器領域預計將在 2024 年佔據更大的市場佔有率。該細分市場的巨大市場佔有率歸因於自動化生物反應器提供的優勢，例如提高製程品質、減少錯誤、優化製程控制和降低成本。自動化生物反應器透過即時監控和數據豐富的品質控制幫助提高品質和生產力。簡化程序和實驗並快速檢測過程偏差。

從應用來看，預計到 2024 年商業生產領域將佔據生物反應器市場的很大佔有率。商業生產包括單株抗體 (mAb) 生產、細胞和基因治療生產、疫苗生產、血漿分級分離和重組蛋白生產。該細分市場的巨大市場佔有率是由生物製藥的日益普及、旨在加速生物仿製藥採用的有利監管改革以及基因療法開發投資的增加所推動的。

從最終用戶來看，生物製藥製造商領域預計將在 2024 年佔據最大佔有率。近年來，由於生物製藥需求的增加、慢性病盛行率的增加、製藥和生物技術公司研發支出的增加以及最近針對慢性和罕見疾病的生物製劑的推出，生物製藥製造商經歷了顯著增長。各國政府正在主動投資、向生物製藥公司提供贈款和資金，用於生物製藥的製造和研發，並共同開發可持續的生物製造方法。這些因素促使生物製藥製造商擴大採用生物反應器，從而為該領域帶來了巨大的市場佔有率。

對全球生物反應器市場區域狀況的詳細分析為五個關鍵區域（北美、歐洲、亞太地區、中東和非洲以及拉丁美洲）以及每個區域的主要國家提供了詳細的定性和定量見解。 。

到2024年，北美預計將佔據全球生物反應器市場的最大佔有率，達到34%，其次是歐洲、亞太地區、拉丁美洲以及中東和非洲。北美市場佔有率大的原因在於主要生物製藥公司的存在、研發投入高、政府和監管機構對促進生物製藥使用的支持以及生物製藥公司擴大生產能力的努力。

目錄

第1章簡介

第2章 研究方法

第3章 執行摘要

第4章 市場洞察

  • 概述
  • 促進因素
    • 生物製藥工廠產能擴張
    • 醫藥市場的成長
    • 藥品研發費用增加
    • 生物相似藥的採用增加
    • 製藥和生物技術產業擴大採用一次性技術
  • 阻礙因素
    • 生物製藥的複雜開發與製造流程
    • 生物製藥製造的密集資金需求
  • 機會
    • 生物反應器技術的進展
    • 更多採用個人化藥物以及細胞和基因療法
  • 任務
    • 使用一次性生物反應器的生物製造過程中的可萃取物和可浸出物 (E&L) 風險
    • 工藝放大限制
    • 一次性生物反應器設計標準化的必要性
    • 關於一次性生物反應器處置的環境問題
  • 科技趨勢/市場趨勢
    • 在商業生產中使用一次性加工設備
    • 越來越重視連續生物加工
    • 轉向生物製程4.0
    • 將人工智慧融入生物加工
  • 監管場景
  • 價格分析
  • 母市場分析
  • 波特五力分析

第5章全球生物反應器市場：按類型

  • 概述
  • 連續攪拌槽生物反應器
  • 氣升式生物反應器
  • 流體化床生物反應器
  • 填充床生物反應器
  • 光生物反應器
    • 開放式生物反應器
    • 封閉系統生物反應器
  • 膜生物反應器

第6章全球生物反應器市場：依生物製程分類

  • 概述
  • 分批/補料分批生物工藝
  • 連續生物過程

第7章全球生物反應器市場：依細胞類型

  • 概述
  • 哺乳動物細胞
  • 細菌細胞
  • 酵母細胞
  • 其他細胞類型

第8章全球生物反應器市場：依應用分類

  • 概述
  • 可重複使用的生物反應器
    • 不銹鋼
    • 玻璃
  • 一次性生物反應器

第9章全球生物反應器市場：依規模

  • 概述
  • 實驗室規模生物反應器（0.5L-10L）
  • 中試規模生物反應器（10L-200L）
  • 工業規模生物反應器
    • 200L 至 500L
    • 500L 至 1000L
    • 1,500L以上

第10章全球生物反應器市場：依應用分類

  • 概述
  • 商業化生產
    • 單株抗體 (mAb) 生產
    • 細胞/基因治療製造
    • 疫苗生產
    • 血漿分數
    • 重組蛋白生產
  • 開發、臨床前、臨床

第11章全球生物反應器市場：依最終用戶分類

  • 概述
  • 生物製藥製造商
  • 研發機構
  • 合約製造組織

第12章生物反應器市場：按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 瑞士
    • 愛爾蘭
    • 丹麥
    • 比利時
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東/非洲

第13章 競爭分析

  • 概述
  • 主要成長策略
  • 競爭標桿
  • 比賽儀表板
    • 市場領導者
    • 差異化因素
    • 龍頭企業
    • 啟動
  • 市場佔有率分析（2023 年）

第14章 公司簡介（公司概況、財務概況、產品組合、策略發展）

  • Thermo Fisher Scientific, Inc.
  • METTLER TOLEDO
  • Merck KGaA
  • Eppendorf AG
  • Sartorius AG
  • Danaher Corporation
  • Donaldson Company, Inc.
  • BBI-Biotech GmbH
  • Infors AG
  • Pharsol Ltd.
  • 其他公司

（註：提供前5名公司的SWOT分析）

第15章附錄

Product Code: MRHC - 1041133

Bioreactors Market Size, Share, Forecast, & Trends Analysis by Type (continuous Stirred Tank, Photobioreactor) Bioprocess (Batch, Continuous) Usability (Reusable, Single-use) Scale (Pilot, Industrial) Cell Type, Application, User-Global Forecast to 2031.

The global bioreactors market is projected to reach $39.96 billion by 2031, at a CAGR of 10.1% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides insights into the key drivers, restraints, opportunities, and challenges of the bioreactors market. The growth of this market is driven by the expansion of biopharmaceutical plants, the growth of the pharmaceuticals sector, increased R&D expenditures in pharmaceuticals, the rising adoption of biosimilars, and the growing adoption of disposable technologies in the pharmaceutical and biotechnology sectors. However, the complex development & manufacturing processes of biopharmaceuticals and high capital requirements for biopharmaceutical production restrain the market's growth.

Moreover, advancements in bioreactor technologies and the rising adoption of personalized medicines and cell & gene therapies are expected to create market growth opportunities. However, risks associated with extractables and leachables (E&L) in biomanufacturing processes using single-use bioreactors, limitations in scaling up biopharmaceutical processes, the need to standardize designs for single-use bioreactors, and environmental concerns related to the disposal of single-use bioreactors are some of the challenges impacting the market's growth.

Based on product, in 2024, the continuous stirred-tank bioreactors segment is expected to account for the largest share of 31% of the bioreactors market. This segment's large market share can be attributed to technological advancements in continuous stirred-tank bioreactors and their capability to handle higher concentrations of reactants due to their superior heat transfer properties compared to other bioreactors. Additionally, market players are enhancing bioreactor designs to integrate seamlessly with existing flow systems. For instance, in October 2024, Vapourtec Ltd. (U.K.) launched a continuous stirred-tank bioreactor designed for continuous process synthesis, specifically designed to work alongside existing flow-chemistry systems.

Based on bioprocess, in 2024, the batch/fed-batch segment is expected to account for the largest share of the bioreactors market. This segment's large market share can be attributed to the advantages of batch/fed-batch bioprocessing, including high productivity, simplified management of bioprocesses, and reduced risks of contamination. The duration of batch processing is ideal for rapid experimentation and accelerates upstream processes, thereby enhancing overall productivity.

Based on cell type, in 2024, the mammalian cells segment is expected to account for the largest share of the bioreactors market. This segment's large market share can be attributed to the increasing focus on commercial and research bioproduction for complex biomolecules such as monoclonal antibodies and therapeutic proteins. Additionally, the growth in clinical research involving mammalian cells has led to their widespread adoption in single-use bioreactors.

Based on usability, in 2024, the reusable bioreactors segment is expected to account for the larger share of the bioreactors market. This segment's large market share can be attributed to the increase in large-scale manufacturing, where reusable bioreactors are increasingly adopted due to their cost efficiency and suitability for handling high volumes of production. Moreover, the high costs and regulatory restrictions associated with waste disposal drive the increased adoption of reusable bioreactors.

Based on scale, the pilot scale bioreactors (10L-200L) segment is slated to register the highest CAGR in the market. Pilot scale bioreactors are systems that are between the capacity of 10L-200L and include multiple variations and customizations. They find extensive application in the food, pharmaceutical, and cosmetics industries, primarily for testing and refining bioprocesses before full-scale production. The increasing demand for commercial bioproduction drives the adoption of pilot scale bioprocessing, as these bioreactors are crucial in assessing efficiency, scalability, and performance under conditions closely resembling industrial settings.

Based on automation, in 2024, the automated bioreactors segment is expected to account for the larger share of the market. This segment's large market share can be attributed to the benefits offered by automated bioreactors, including enhanced process quality, reduced errors, optimized process control, and cost savings. Automated bioreactors contribute to improved quality and productivity through real-time monitoring and data-rich quality control. They streamline procedures and experiments, ensuring swift detection of deviations in processes.

Based on application, in 2024, the commercial production segment is expected to account for the larger share of the bioreactors market. The commercial production consists of monoclonal antibodies (mAb) production, cell & gene therapy production, vaccine manufacturing, plasma fractionation, and recombinant protein production. This segment's large market share can be attributed to the growing adoption of biopharmaceuticals, favorable regulatory reforms aimed at promoting the adoption of biosimilars, and rising investments in developing gene therapies.

Based on end user, in 2024, the biopharmaceutical manufacturers segment is expected to account for the largest share of the market. Biopharmaceutical companies have witnessed significant growth in recent years due to the increasing demand for biopharmaceuticals, growing incidence of chronic diseases, rising R&D expenditure by pharmaceutical & biotechnology companies, and recent launches of biologics for chronic & rare diseases. Governments of various countries are taking initiatives by making investments and providing grants & funds to biopharmaceutical companies for the manufacture and R&D of biopharmaceuticals, along with several companies that are collaborating to develop sustainable methods for biomanufacturing. These factors contribute to the increased adoption of bioreactors among biopharmaceutical manufacturers, contributing to the segment's large market share.

An in-depth analysis of the geographical scenario of the global bioreactors market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.

In 2024, North America is expected to account for the largest share of 34% of the global bioreactors market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America's significant market share can be attributed to the presence of large biopharmaceutical companies, high R&D investments, support from government and regulatory authorities to promote the use of biopharmaceuticals, and initiatives by biopharmaceutical companies to expand their manufacturing capacities.

The key players operating in the global bioreactors market are Thermo Fisher Scientific, Inc. (U.S.), METTLER TOLEDO (U.S.), Merck KGaA (Germany), Eppendorf AG (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Donaldson Company, Inc. (U.S.), BBI-Biotech GmbH (Germany), Infors AG (Switzerland), and Pharsol Ltd. (Slovenia).

Scope of the Report:

Bioreactors Market-by Product

  • Continuous Stirred Tank Bioreactors
  • Airlift Bioreactors
  • Fluidized-bed Bioreactors
  • Packed-bed Bioreactors
  • Photobioreactors
    • Open System Photobioreactors
    • Closed System Photobioreactors
  • Membrane Bioreactors

Bioreactors Market-by Bioprocess

  • Batch/Fed-batch Bioprocessing
  • Continuous Bioprocessing

Bioreactors Market-by Cell Type

  • Mammalian Cells
  • Bacterial Cells
  • Yeast Cells
  • Other Cell Types

(Other cell types include plant cells and insect cells)

Bioreactors Market-by Usability

  • Reusable Bioreactors
    • Reusable Bioreactors by Material
  • Stainless Steel
  • Glass
  • Single-use Bioreactors

Bioreactors Market-by Scale

  • Lab Scale Bioreactors (0.5L-10L)
  • Pilot Scale Bioreactors (10L-200L)
  • Industrial Scale Bioreactors
    • 200L-500L
    • 500L-1000L
    • Above 1,500L

Bioreactors Market-by Automation

  • Manual/Semi-automated Bioreactors
  • Automated Bioreactors

Bioreactors Market-by Application

  • Commercial Production
    • Monoclonal Antibodies (mAb) Production
    • Cell & Gene Therapy Production
    • Vaccine Manufacturing
    • Plasma Fractionation
    • Recombinant Protein Production
  • Developmental, Preclinical, & Clinical

Bioreactors Market-by End User

  • Biopharmaceutical Manufacturers
  • Research & Development Organizations
  • Contract Manufacturing Organizations

Bioreactors Market-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Switzerland
    • Ireland
    • Denmark
    • Belgium
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumption for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Capacity Expansion of Biopharmaceutical Plants
    • 4.2.2. Growing Pharmaceutical Market
    • 4.2.3. Rising Pharmaceutical R&D Expenditures
    • 4.2.4. Rising Adoption of Biosimilars
    • 4.2.5. Growing Adoption of Disposable Technologies in the Pharmaceutical and Biotechnology Industries
  • 4.3. Restraints
    • 4.3.1. Complex Development and Manufacturing Process of Biopharmaceuticals
    • 4.3.2. Intensive Capital Requirements for Biopharmaceuticals Production
  • 4.4. Opportunities
    • 4.4.1. Technological Advancements in Bioreactor Technologies
    • 4.4.2. Rising Adoption of Personalized Medicines and Cell & Gene Therapies
  • 4.5. Challenges
    • 4.5.1. Risk of Extractables and Leachables (E&L) in Biomanufacturing Processes Using Single-use Bioreactors
    • 4.5.2. Process Scale-up Limitations
    • 4.5.3. Need to Standardize Single-use Bioreactor Designs
    • 4.5.4. Environmental Concerns Related to the Disposal of Single-use Bioreactors
  • 4.6. Technology Trends/Market Trends
    • 4.6.1. Use of Disposable Processing Equipment for Commercial Production
    • 4.6.2. Rising Focus on Continuous Bioprocessing
    • 4.6.3. Shift Towards Bioprocessing 4.0
    • 4.6.4. Integration of AI in Bioprocessing
  • 4.7. Regulatory Scenario
  • 4.8. Pricing Analysis
  • 4.9. Parent Market Analysis
  • 4.10 Porter's Five Forces Analysis

5. Global Bioreactors Market-by Type

  • 5.1. Overview
  • 5.2. Continuous Stirred-tank Bioreactors
  • 5.3. Airlift Bioreactors
  • 5.4. Fluidized-bed Bioreactors
  • 5.5. Packed-bed Bioreactors
  • 5.6. Photobioreactors
    • 5.6.1. Open System Bioreactors
    • 5.6.2. Closed System Bioreactors
  • 5.7. Membrane Bioreactors

6. Global Bioreactors Market-by Bioprocess

  • 6.1. Overview
  • 6.2. Batch/Fed-batch Bioprocessing
  • 6.3. Continuous Bioprocessing

7. Global Bioreactors Market-by Cell Type

  • 7.1. Overview
  • 7.2. Mammalian Cells
  • 7.3. Bacterial Cells
  • 7.4. Yeast Cells
  • 7.5. Other Cell Types

8. Global Bioreactors Market-by Usability

  • 8.1. Overview
  • 8.2. Reusable Bioreactors
    • 8.2.1. Stainless Steel
    • 8.2.2. Glass
  • 8.3. Single-use Bioreactors

9. Global Bioreactors Market-by Scale

  • 9.1. Overview
  • 9.2. Lab Scale Bioreactors (0.5L-10L)
  • 9.3. Pilot Scale Bioreactors (10L-200L)
  • 9.4. Industrial Scale Bioreactors
    • 9.4.1. 200L-500L
    • 9.4.2. 500L-1000L
    • 9.4.3. Above 1,500L

10. Global Bioreactors Market-by Application

  • 10.1. Overview
  • 10.2. Commercial Production
    • 10.2.1. Monoclonal Antibodies (mAb) Production
    • 10.2.2. Cell & Gene Therapy Production
    • 10.2.3. Vaccine Manufacturing
    • 10.2.4. Plasma Fractionation
    • 10.2.5. Recombinant Protein Production
  • 10.3. Development, Preclinical, & Clinical

11. Global Bioreactors Market-by End User

  • 11.1. Overview
  • 11.2. Biopharmaceutical Manufacturers
  • 11.3. Research & Development Organizations
  • 11.4. Contract Manufacturing Organizations

12. Bioreactors Market-by Geography

  • 12.1. Overview
  • 12.2. North America
    • 12.2.1. U.S.
    • 12.2.2. Canada
  • 12.3. Europe
    • 12.3.1. Germany
    • 12.3.2. France
    • 12.3.3. U.K.
    • 12.3.4. Italy
    • 12.3.5. Spain
    • 12.3.6. Switzerland
    • 12.3.7. Ireland
    • 12.3.8. Denmark
    • 12.3.9. Belgium
    • 12.3.10. Rest of Europe
  • 12.4. Asia-Pacific
    • 12.4.1. Japan
    • 12.4.2. China
    • 12.4.3. India
    • 12.4.4. South Korea
    • 12.4.5. Rest of Asia Pacific
  • 12.5. Latin America
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Middle East & Africa

13. Competition Analysis

  • 13.1. Overview
  • 13.2. Key Growth Strategies
  • 13.3. Competitive Benchmarking
  • 13.4. Competitive Dashboard
    • 13.4.1. Market Leaders
    • 13.4.2. Market Differentiators
    • 13.4.3. Vanguards
    • 13.4.4. Emerging Companies
  • 13.5. Market Share Analysis (2023)

14. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 14.1. Thermo Fisher Scientific, Inc.
  • 14.2. METTLER TOLEDO
  • 14.3. Merck KGaA
  • 14.4. Eppendorf AG
  • 14.5. Sartorius AG
  • 14.6. Danaher Corporation
  • 14.7. Donaldson Company, Inc.
  • 14.8. BBI-Biotech GmbH
  • 14.9. Infors AG
  • 14.10. Pharsol Ltd.
  • 14.11. Other Companies

(Note: SWOT analysis of the top 5 companies will be provided.)

15. Appendix

  • 15.1. Available Customization
  • 15.2. Related Reports

LIST OF TABLES

  • Table 1 Global Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 2 Global Continuous Stirred-tank Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 3 Global Airlift Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Fluidized-bed Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 5 Global Packed-bed Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 7 Global Photobioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global Open System Photobioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 9 Global Closed System Photobioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 10 Global Membrane Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 12 Global Batch/Fed-batch Bioprocessing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 13 Global Continuous Bioprocessing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 15 Global Bioreactors Market for Mammalian Cells, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Bioreactors Market for Bacterial Cells, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Bioreactors Market for Yeast Cells, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Bioreactors Market for Other Cells, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 20 Global Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 21 Global Reusable Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Global Stainless Steel based Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global Glass-based Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Global Single-use Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Global Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 26 Global Lab Scale Bioreactors (0.5L-10L) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global Pilot Scale Bioreactors (10L-200L) Market, by Country/Region, 2022-2031 (USD Million)
  • Table 28 Global Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 29 Global Industrial Scale Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Global 200L-500L Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 31 Global 500L-1000L Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Above 1,500L Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 34 Global Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 35 Global Monoclonal Antibodies (mAb) Production Market, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global Cell & Gene Therapy Production Market, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Global Vaccine Manufacturing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 38 Global Plasma Fractionation Market, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Recombinant Protein Production Market, by Country/Region, 2022-2031 (USD Million)
  • Table 40 Global Bioreactors Market for Developmental, Preclinical & Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 41 Global Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 42 Global Bioreactors Market for Biopharmaceutical Manufacturers, by Country/Region, 2022-2031 (USD Million)
  • Table 43 Global Bioreactors Market for Research & Development Organizations, by Country/Region, 2022-2031 (USD Million)
  • Table 44 Global Bioreactors Market for Contract Manufacturing Organizations, by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 46 North America: Bioreactors Market, by Country, 2022-2031 (USD Million)
  • Table 47 North America: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 48 North America: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 49 North America: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 50 North America: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 51 North America: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 52 North America: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 53 North America: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 54 North America: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 55 North America: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 56 North America: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 57 North America: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 58 U.S.: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 59 U.S.: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 60 U.S.: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 61 U.S.: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 62 U.S.: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 63 U.S.: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 64 U.S.: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 65 U.S.: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 66 U.S.: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 67 U.S.: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 68 U.S.: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 69 Canada: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 70 Canada: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 71 Canada: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 72 Canada: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 73 Canada: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 74 Canada: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 75 Canada: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 76 Canada: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 77 Canada: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 78 Canada: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 79 Canada: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 80 Europe: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 81 Europe: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 82 Europe: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 83 Europe: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 84 Europe: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 85 Europe: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 86 Europe: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 87 Europe: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 88 Europe: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 89 Europe: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 90 Europe: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 91 Europe: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 92 Germany: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 93 Germany: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 94 Germany: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 95 Germany: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 96 Germany: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 97 Germany: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 98 Germany: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 99 Germany: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 100 Germany: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 101 Germany: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 102 Germany: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 103 France: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 104 France: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 105 France: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 106 France: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 107 France: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 108 France: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 109 France: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 110 France: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 111 France: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 112 France: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 113 France: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 114 U.K.: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 115 U.K.: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 116 U.K.: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 117 U.K.: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 118 U.K.: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 119 U.K.: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 120 U.K.: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 121 U.K.: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 122 U.K.: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 123 U.K.: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 124 U.K.: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 125 Italy: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 126 Italy: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 127 Italy: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 128 Italy: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 129 Italy: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 130 Italy: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 131 Italy: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 132 Italy: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 133 Italy: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 134 Italy: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 135 Italy: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 136 Spain: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 137 Spain: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 138 Spain: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 139 Spain: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 140 Spain: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 141 Spain: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 142 Spain: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 143 Spain: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 144 Spain: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 145 Spain: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 146 Spain: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 147 Switzerland: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 148 Switzerland: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 149 Switzerland: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 150 Switzerland: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 151 Switzerland: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 152 Switzerland: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 153 Switzerland: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 154 Switzerland: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 155 Switzerland: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 156 Switzerland: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 157 Switzerland: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 158 Ireland: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 159 Ireland: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 160 Ireland: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 161 Ireland: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 162 Ireland: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 163 Ireland: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 164 Ireland: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 165 Ireland: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 166 Ireland: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 167 Ireland: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 168 Ireland: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 169 Denmark: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 170 Denmark: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 171 Denmark: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 172 Denmark: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 173 Denmark: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 174 Denmark: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 175 Denmark: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 176 Denmark: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 177 Denmark: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 178 Denmark: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 179 Denmark: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 180 Belgium: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 181 Belgium: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 182 Belgium: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 183 Belgium: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 184 Belgium: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 185 Belgium: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 186 Belgium: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 187 Belgium: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 188 Belgium: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 189 Belgium: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 190 Belgium: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 191 Rest of Europe: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 192 Rest of Europe: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 193 Rest of Europe: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 194 Rest of Europe: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 195 Rest of Europe: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 196 Rest of Europe: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 197 Rest of Europe: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 198 Rest of Europe: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 199 Rest of Europe: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 200 Rest of Europe: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 201 Rest of Europe: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 202 Asia-Pacific: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 203 Asia-Pacific: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 204 Asia-Pacific: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 205 Asia-Pacific: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 206 Asia-Pacific: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 207 Asia-Pacific: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 208 Asia-Pacific: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 209 Asia-Pacific: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 210 Asia-Pacific: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 211 Asia-Pacific: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 212 Asia-Pacific: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 213 Asia-Pacific: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 214 Japan: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 215 Japan: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 216 Japan: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 217 Japan: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 218 Japan: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 219 Japan: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 220 Japan: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 221 Japan: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 222 Japan: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 223 Japan: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 224 Japan: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 225 China: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 226 China: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 227 China: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 228 China: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 229 China: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 230 China: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 231 China: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 232 China: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 233 China: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 234 China: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 235 China: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 236 India: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 237 India: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 238 India: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 239 India: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 240 India: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 241 India: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 242 India: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 243 India: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 244 India: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 245 India: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 246 India: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 247 South Korea: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 248 South Korea: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 249 South Korea: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 250 South Korea: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 251 South Korea: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 252 South Korea: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 253 South Korea: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 254 South Korea: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 255 South Korea: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 256 South Korea: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 257 South Korea: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 258 Rest of Asia-Pacific: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 259 Rest of Asia-Pacific: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 260 Rest of Asia-Pacific: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 261 Rest of Asia-Pacific: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 262 Rest of Asia-Pacific: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 263 Rest of Asia-Pacific: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 264 Rest of Asia-Pacific: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 265 Rest of Asia-Pacific: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 266 Rest of Asia-Pacific: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 267 Rest of Asia-Pacific: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 268 Rest of Asia-Pacific: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 269 Latin America: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 270 Latin America: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 271 Latin America: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 272 Latin America: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 273 Latin America: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 274 Latin America: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 275 Latin America: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 276 Latin America: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 277 Latin America: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 278 Latin America: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 279 Latin America: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 280 Latin America: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 281 Brazil: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 282 Brazil: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 283 Brazil: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 284 Brazil: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 285 Brazil: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 286 Brazil: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 287 Brazil: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 288 Brazil: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 289 Brazil: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 290 Brazil: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 291 Brazil: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 292 Mexico: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 293 Mexico: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 294 Mexico: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 295 Mexico: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 296 Mexico: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 297 Mexico: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 298 Mexico: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 299 Mexico: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 300 Mexico: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 301 Mexico: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 302 Mexico: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 303 Rest of Latin America: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 304 Rest of Latin America: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 305 Rest of Latin America: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 306 Rest of Latin America: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 307 Rest of Latin America: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 308 Rest of Latin America: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 309 Rest of Latin America: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 310 Rest of Latin America: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 311 Rest of Latin America: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 312 Rest of Latin America: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 313 Rest of Latin America: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 314 Middle East & Africa: Bioreactors Market, by Country/Region, 2022-2031 (USD Million)
  • Table 315 Middle East & Africa: Bioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 316 Middle East & Africa: Photobioreactors Market, by Type, 2022-2031 (USD Million)
  • Table 317 Middle East & Africa: Bioreactors Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 318 Middle East & Africa: Bioreactors Market, by Cell Type, 2022-2031 (USD Million)
  • Table 319 Middle East & Africa: Bioreactors Market, by Usability, 2022-2031 (USD Million)
  • Table 320 Middle East & Africa: Reusable Bioreactors Market, by Material, 2022-2031 (USD Million)
  • Table 321 Middle East & Africa: Bioreactors Market, by Scale, 2022-2031 (USD Million)
  • Table 322 Middle East & Africa: Industrial Scale Bioreactors Market, by Capacity, 2022-2031 (USD Million)
  • Table 323 Middle East & Africa: Bioreactors Market, by Application, 2022-2031 (USD Million)
  • Table 324 Middle East & Africa: Bioreactors Market for Commercial Production, by Application, 2022-2031 (USD Million)
  • Table 325 Middle East & Africa: Bioreactors Market, by End User, 2022-2031 (USD Million)
  • Table 326 Recent Developments, by Company, 2020-2024

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Bioreactors Market, by Type, 2024 VS. 2031 (USD Million)
  • Figure 8 Global Bioreactors Market, by Bioprocess, 2024 VS. 2031 (USD Million)
  • Figure 9 Global Bioreactors Market, by Cell Type, 2024 VS. 2031 (USD Million)
  • Figure 10 Global Bioreactors Market, by Usability, 2024 VS. 2031 (USD Million)
  • Figure 11 Global Bioreactors Market, by Scale, 2024 VS. 2031 (USD Million)
  • Figure 12 Global Bioreactors Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 13 Global Bioreactors Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 14 Global Bioreactors Market, by Geography
  • Figure 15 Global Bioreactors Market, by Product, 2024 VS. 2031 (USD Million)
  • Figure 16 Global Bioreactors Market, by Bioprocess, 2024 VS. 2031 (USD Million)
  • Figure 17 Global Bioreactors Market, by Cell Type, 2024 VS. 2031 (USD Million)
  • Figure 18 Global Bioreactors Market, by Usability, 2024 VS. 2031 (USD Million)
  • Figure 19 Global Bioreactors Market, by Scale, 2024 VS. 2031 (USD Million)
  • Figure 20 Global Bioreactors Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 21 Global Bioreactors Market, by End User, 2024 VS. 2031 (USD Million)
  • Figure 22 Global Bioreactors Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 23 North America: Bioreactors Market Snapshot
  • Figure 24 Europe: Bioreactors Market Snapshot
  • Figure 25 Asia-Pacific: Bioreactors Market Snapshot
  • Figure 26 Latin America: Bioreactors Market Snapshot
  • Figure 27 Key Growth Strategies Adopted by Leading Players, 2020-2024
  • Figure 28 Global Bioreactors Market: Competitive Benchmarking, by Product
  • Figure 29 Global Bioreactors Market: Competitive Dashboard
  • Figure 30 Global Bioreactors Market: Market Share Analysis/Market Ranking (2024)
  • Figure 31 Thermo Fisher Scientific, Inc.: Financial Overview (2024)
  • Figure 32 Merck KGaA: Financial Overview (2024)
  • Figure 33 Eppendorf AG: Financial Overview (2022)
  • Figure 34 Sartorius AG: Financial Overview (2022)
  • Figure 35 Danaher Corporation: Financial Overview (2024)
  • Figure 36 Donaldson Company, Inc.: Financial Overview (2024)